1214 related articles for article (PubMed ID: 33190637)
21. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
[TBL] [Abstract][Full Text] [Related]
22. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy of anti-diabetic medications as add-on to metformin in type 2 diabetes mellitus from a real-world database.
Ono R; Ogami C; Hasegawa C; To H; Matsumoto Y; Tsuji Y
BMC Pharmacol Toxicol; 2023 Dec; 24(1):75. PubMed ID: 38066653
[TBL] [Abstract][Full Text] [Related]
24. Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years.
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
J Alzheimers Dis; 2020; 76(4):1581-1594. PubMed ID: 32741836
[TBL] [Abstract][Full Text] [Related]
25. SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO.
Lingvay I
Endocr Pract; 2017 Jul; 23(7):831-840. PubMed ID: 28332871
[TBL] [Abstract][Full Text] [Related]
26. Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study.
Bramante CT; Johnson SG; Garcia V; Evans MD; Harper J; Wilkins KJ; Huling JD; Mehta H; Alexander C; Tronieri J; Hong S; Kahkoska A; Alamgir J; Koraishy F; Hartman K; Yang K; Abrahamsen T; Stürmer T; Buse JB;
PLoS One; 2022; 17(11):e0271574. PubMed ID: 36395143
[TBL] [Abstract][Full Text] [Related]
27. Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.
Nassar M; Abosheaishaa H; Singh AK; Misra A; Bloomgarden Z
J Diabetes; 2023 Feb; 15(2):86-96. PubMed ID: 36690377
[TBL] [Abstract][Full Text] [Related]
28. Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis.
Zhu Z; Zeng Q; Liu Q; Wen J; Chen G
JAMA Netw Open; 2022 Dec; 5(12):e2244652. PubMed ID: 36472874
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
Seufert J; Pegelow K; Bramlage P
Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Wang Z; Sun J; Han R; Fan D; Dong X; Luan Z; Xiang R; Zhao M; Yang J
Diabetes Obes Metab; 2018 Jan; 20(1):113-120. PubMed ID: 28656707
[TBL] [Abstract][Full Text] [Related]
31. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
Jornayvaz FR; Assouline B; Pugin J; Gariani K
BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
[TBL] [Abstract][Full Text] [Related]
32. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study.
Jiménez E; Fontán-Vela M; Valencia J; Fernandez-Jimenez I; Álvaro-Alonso EA; Izquierdo-García E; Lazaro Cebas A; Gallego Ruiz-Elvira E; Troya J; Tebar-Martinez AJ; Garcia-Marina B; Peña-Lillo G; Abad-Motos A; Macaya L; Ryan P; Pérez-Butragueño M; ;
BMJ Open; 2020 Nov; 10(11):e042398. PubMed ID: 33172949
[TBL] [Abstract][Full Text] [Related]
33. Early prediction of level-of-care requirements in patients with COVID-19.
Hao B; Sotudian S; Wang T; Xu T; Hu Y; Gaitanidis A; Breen K; Velmahos GC; Paschalidis IC
Elife; 2020 Oct; 9():. PubMed ID: 33044170
[TBL] [Abstract][Full Text] [Related]
34. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.
Carrasco-Sánchez FJ; López-Carmona MD; Martínez-Marcos FJ; Pérez-Belmonte LM; Hidalgo-Jiménez A; Buonaiuto V; Suárez Fernández C; Freire Castro SJ; Luordo D; Pesqueira Fontan PM; Blázquez Encinar JC; Magallanes Gamboa JO; de la Peña Fernández A; Torres Peña JD; Fernández Solà J; Napal Lecumberri JJ; Amorós Martínez F; Guisado Espartero ME; Jorge Ripper C; Gómez Méndez R; Vicente López N; Román Bernal B; Rojano Rivero MG; Ramos Rincón JM; Gómez Huelgas R;
Ann Med; 2021 Dec; 53(1):103-116. PubMed ID: 33063540
[TBL] [Abstract][Full Text] [Related]
35. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
Singh AK; Singh R; Saboo B; Misra A
Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
[TBL] [Abstract][Full Text] [Related]
36. Risk of ICU Admission and Related Mortality in Patients With Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors: A Territory-Wide Retrospective Cohort Study.
Ng PY; Ng AK; Ip A; Wu MZ; Guo R; Yiu KH
Crit Care Med; 2023 Aug; 51(8):1074-1085. PubMed ID: 37026864
[TBL] [Abstract][Full Text] [Related]
37. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
38. Metformin monotherapy for adults with type 2 diabetes mellitus.
Gnesin F; Thuesen ACB; Kähler LKA; Madsbad S; Hemmingsen B
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012906. PubMed ID: 32501595
[TBL] [Abstract][Full Text] [Related]
39. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
Chen Y; Lv X; Lin S; Arshad M; Dai M
Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
[TBL] [Abstract][Full Text] [Related]
40. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
